Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 9 Jun 23 EFFECT Notice of effectiveness
- 8 Jun 23 POS AM Prospectus update (post-effective amendment)
- 8 Nov 22 EFFECT Notice of effectiveness
-
27 Oct 22 S-3 Shelf registration
STSA similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 15, 2022, with respect to the financial statements of Satsuma Pharmaceuticals, Inc., incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Diego, California
October 27, 2022